Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer

NCT05724849 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Issues with funding

Conditions

Head and Neck Cancer
Depression

Interventions

DRUG: Venlafaxine
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center